Join Now

Author Archives: Press Release

bioMérieux Celebrates New Regional Headquarters in Riyadh, Saudi Arabia

By Press Release | Published December 4, 2025

bioMérieux Celebrates New Regional Headquarters in Riyadh, Saudi Arabia

Posted in BioUtah News | Tagged | Comments Off on bioMérieux Celebrates New Regional Headquarters in Riyadh, Saudi Arabia

PolarityBio Completes Phase III Pivotal Study of SkinTE for Diabetic Foot Ulcers

By Press Release | Published December 4, 2025

PolarityBio thanks the clinical trial sites and, most importantly, the participants, for making this milestone in DFU biologic therapy development possible

Posted in BioUtah News | Tagged | Comments Off on PolarityBio Completes Phase III Pivotal Study of SkinTE for Diabetic Foot Ulcers

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

By Press Release | Published December 4, 2025

Milestone enables immediate production of SiN/PEEK custom devices

Posted in BioUtah News | Tagged | Comments Off on SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

5 Trends to Expect From Vocal Biomarker Technology in 2026

By Press Release | Published December 4, 2025

By Henry O’Connell, CEO and co-founder of Canary Speech   Vocal biomarker data has come a long way in a short amount of time. No longer relegated to the pages of science fiction, the power of the human voice to assist in diagnoses is established fact. Providers already possess technological platforms that make informed care […]

Posted in BioUtah News | Tagged | Comments Off on 5 Trends to Expect From Vocal Biomarker Technology in 2026

Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs

By Press Release | Published November 13, 2025

100% of genes strongly recommended by national oncology guidelines are included in the MyRisk Test.

Posted in BioUtah News | Tagged | Comments Off on Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs

New Preclinical Study Demonstrates Feasibility of Microbubble-Mediated, Non-Thermal Focused Ultrasound for Brain Tumor Ablation

By Press Release | Published November 13, 2025

Salt Lake City, UT –Wednesday November, 5th 2025— Researchers from the University of Utah and Microvascular Therapeutics (MVT) will be presenting new preclinical data demonstrating that focused ultrasound (FUS) using proprietary phase-shift microbubbles, NanoBlate (MVT-101), can selectively ablate brain tumors and open the blood-brain barrier (BBB) in targeted regions, potentially enabling safer, more precise, and […]

Posted in BioUtah News | Tagged | Comments Off on New Preclinical Study Demonstrates Feasibility of Microbubble-Mediated, Non-Thermal Focused Ultrasound for Brain Tumor Ablation

Owlet Partners with Rhapsody to Connect Remote Baby Monitoring Data to EHRs

By Press Release | Published November 13, 2025

Collaboration bridges home and hospital, creating a secure pathway for pediatric insights to be managed and shared.

Posted in BioUtah News | Tagged | Comments Off on Owlet Partners with Rhapsody to Connect Remote Baby Monitoring Data to EHRs

J3 Bioscience Announces Collaboration to Study LIV-Ring VR101 for Cancer-Therapy–Related Vaginal Dryness

By Press Release | Published November 13, 2025

Investigator-Initiated, grant-supported pilot study evaluating a novel non-prescription therapy for cancer-related vaginal dryness.

Posted in BioUtah News | Tagged | Comments Off on J3 Bioscience Announces Collaboration to Study LIV-Ring VR101 for Cancer-Therapy–Related Vaginal Dryness

2025 BioUtah Life Sciences Awards Presented at the Mayer Brown Utah Life Sciences Summit

By Press Release | Published November 13, 2025

BioUtah will honor outstanding leaders in Utah’s life sciences community with five awards recognizing contributions to the industry.

Posted in BioUtah News | Tagged | Comments Off on 2025 BioUtah Life Sciences Awards Presented at the Mayer Brown Utah Life Sciences Summit

PhotoPharmics Surpasses Enrollment Target with 350 Participants in First-of-a-Kind Remote, Home-Based Phase 3 “Light for PD” Clinical Trial

By Press Release | Published November 6, 2025

PhotoPharmics Surpasses Enrollment Target with 350 Participants in First-of-a-Kind Remote, Home-Based Phase 3 “Light for PD” Clinical Trial

Posted in BioUtah News | Tagged | Comments Off on PhotoPharmics Surpasses Enrollment Target with 350 Participants in First-of-a-Kind Remote, Home-Based Phase 3 “Light for PD” Clinical Trial

Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial

By Press Release | Published November 6, 2025

The target lesion primary patency (TLPP)1 and access circuit primary patency (ACPP)2 of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) remain superior to percutaneous transluminal angioplasty (PTA) through 24 months

Posted in BioUtah News | Tagged | Comments Off on Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial

Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis

By Press Release | Published November 6, 2025

Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis

Posted in BioUtah News | Tagged | Comments Off on Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis

A Special Thanks To Our Elite Members